Iodixanol Versus Low-Osmolar Contrast Media for Prevention of Contrast Induced Nephropathy | Zendy

Aaron M. From | Zendy; Firas Al Badarin | Zendy; Furman S. McDonald | Zendy; Brian J. Bartholmai | Zendy; S. Stephen | Zendy; Charanjit S. Rihal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Iodixanol Versus Low-Osmolar Contrast Media for Prevention of Contrast Induced Nephropathy

Author(s) -

Aaron M. From,

Firas Al Badarin,

Furman S. McDonald,

Brian J. Bartholmai,

S. Stephen,

Charanjit S. Rihal

Publication year - 2010

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.109.917070

Subject(s) - iodixanol , medicine , contrast induced nephropathy , nephropathy , iohexol , odds ratio , randomized controlled trial , confidence interval , placebo , population , percutaneous coronary intervention , urology , contrast medium , radiology , renal function , pathology , myocardial infarction , endocrinology , alternative medicine , environmental health , diabetes mellitus

Contrast-induced nephropathy (CIN) is associated with significant morbidity and mortality. The objective of our meta-analysis was to assess the efficacy of iodixanol compared with low-osmolar contrast media (LOCM) for prevention of CIN.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research